IMM — ImmuPharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual balance sheet for ImmuPharma, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	5.86	1.65	0.668	0.208	0.187
Net Total Accounts Receivable
Net Total Receivables	0.482	1.13	1.34	0.686	0.429
Prepaid Expenses
Total Other Current Assets
Total Current Assets	7.43	3.35	2.34	1.34	0.885
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.412	0.353	0.39	0.102	0.082
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	10.9	6	3.97	2.72	0.977
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	1.26	1.58	1.45	1.67	1.52
Total Long Term Debt
Total Debt
Total Liabilities	1.26	1.58	1.45	1.67	1.52
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	9.65	4.41	2.52	1.06	-0.543
Total Liabilities & Shareholders' Equity	10.9	6	3.97	2.72	0.977
Total Common Shares Outstanding